China Shineway Pharmaceutical Group (HKG:2877) reported 614.7 million yuan in attributable profit for the first half of 2025, down 2% from 626.5 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.
Earnings per share were 0.81 yuan, compared with 0.83 yuan in the prior year.
Revenue decreased 21% year-on-year to 1.65 billion yuan, figures showed.
The pharmaceutical company declared a dividend of HK$0.12 per share, payable Sept. 26 to shareholders of record on Sept. 12.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.